{
 "url": "https://etfiq.com/funds/xph/holdings/",
 "section": "funds",
 "title": "XPH Holdings: All 62 Positions (Oct 13, 2026) | ETFIQ",
 "description": "All 62 XPH holdings with weights, as of Oct 13, 2026. The top 3 are XERS 2.75%, PCRX 2.64% and MANE 2.43%. Download the full list as a CSV.",
 "as_of": "Oct 13, 2026",
 "ticker": "XPH",
 "fund": "State Street SPDR S&P Pharmaceuticals ETF",
 "fund_page": "https://etfiq.com/funds/xph",
 "positions": 62,
 "positions_listed_on_page": 62,
 "lead": "XPH held 62 positions as of Oct 13, 2026. Xeris Biopharma Holdings Inc is the largest at 2.75%; the top 10 are 23.2% of the fund.",
 "source": {
  "name": "State Street",
  "url": "https://www.ssga.com/us/en/intermediary/library-content/products/fund-data/etfs/us/holdings-daily-us-en-xph.xlsx",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-13",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Xeris Biopharma Holdings Inc",
   "ticker": "XERS",
   "weight_pct": 2.755,
   "page": null
  },
  {
   "rank": 2,
   "holding": "Pacira BioSciences Inc",
   "ticker": "PCRX",
   "weight_pct": 2.636,
   "page": "https://etfiq.com/holdings/pcrx/"
  },
  {
   "rank": 3,
   "holding": "VeraDermics Inc",
   "ticker": "MANE",
   "weight_pct": 2.429,
   "page": null
  },
  {
   "rank": 4,
   "holding": "Amneal Pharmaceuticals Inc",
   "ticker": "AMRX",
   "weight_pct": 2.363,
   "page": "https://etfiq.com/holdings/amrx/"
  },
  {
   "rank": 5,
   "holding": "Perrigo Co PLC",
   "ticker": "PRGO",
   "weight_pct": 2.232,
   "page": "https://etfiq.com/holdings/prgo/"
  },
  {
   "rank": 6,
   "holding": "Ligand Pharmaceuticals Inc",
   "ticker": "LGND",
   "weight_pct": 2.194,
   "page": "https://etfiq.com/holdings/lgnd/"
  },
  {
   "rank": 7,
   "holding": "Viatris Inc",
   "ticker": "VTRS",
   "weight_pct": 2.177,
   "page": "https://etfiq.com/holdings/vtrs/"
  },
  {
   "rank": 8,
   "holding": "Eli Lilly & Co",
   "ticker": "LLY",
   "weight_pct": 2.159,
   "page": "https://etfiq.com/holdings/lly/"
  },
  {
   "rank": 9,
   "holding": "Pfizer Inc",
   "ticker": "PFE",
   "weight_pct": 2.127,
   "page": "https://etfiq.com/holdings/pfe/"
  },
  {
   "rank": 10,
   "holding": "Indivior Pharmaceuticals Inc",
   "ticker": "INDV",
   "weight_pct": 2.122,
   "page": "https://etfiq.com/holdings/indv/"
  },
  {
   "rank": 11,
   "holding": "Corcept Therapeutics Inc",
   "ticker": "CORT",
   "weight_pct": 2.121,
   "page": "https://etfiq.com/holdings/cort/"
  },
  {
   "rank": 12,
   "holding": "Zoetis Inc",
   "ticker": "ZTS",
   "weight_pct": 2.111,
   "page": "https://etfiq.com/holdings/zts/"
  },
  {
   "rank": 13,
   "holding": "Organon & Co",
   "ticker": "OGN",
   "weight_pct": 2.098,
   "page": "https://etfiq.com/holdings/ogn/"
  },
  {
   "rank": 14,
   "holding": "ANI Pharmaceuticals Inc",
   "ticker": "ANIP",
   "weight_pct": 2.087,
   "page": "https://etfiq.com/holdings/anip/"
  },
  {
   "rank": 15,
   "holding": "Supernus Pharmaceuticals Inc",
   "ticker": "SUPN",
   "weight_pct": 2.08,
   "page": "https://etfiq.com/holdings/supn/"
  },
  {
   "rank": 16,
   "holding": "Prestige Consumer Healthcare Inc",
   "ticker": "PBH",
   "weight_pct": 2.074,
   "page": "https://etfiq.com/holdings/pbh/"
  },
  {
   "rank": 17,
   "holding": "Innoviva Inc",
   "ticker": "INVA",
   "weight_pct": 2.044,
   "page": "https://etfiq.com/holdings/inva/"
  },
  {
   "rank": 18,
   "holding": "Omeros Corp",
   "ticker": "OMER",
   "weight_pct": 2.028,
   "page": null
  },
  {
   "rank": 19,
   "holding": "Maze Therapeutics Inc",
   "ticker": "MAZE",
   "weight_pct": 2.01,
   "page": null
  },
  {
   "rank": 20,
   "holding": "Merck & Co Inc",
   "ticker": "MRK",
   "weight_pct": 2.004,
   "page": "https://etfiq.com/holdings/mrk/"
  },
  {
   "rank": 21,
   "holding": "Elanco Animal Health Inc",
   "ticker": "ELAN",
   "weight_pct": 1.982,
   "page": "https://etfiq.com/holdings/elan/"
  },
  {
   "rank": 22,
   "holding": "Royalty Pharma PLC",
   "ticker": "RPRX",
   "weight_pct": 1.944,
   "page": "https://etfiq.com/holdings/rprx/"
  },
  {
   "rank": 23,
   "holding": "Johnson & Johnson",
   "ticker": "JNJ",
   "weight_pct": 1.939,
   "page": "https://etfiq.com/holdings/jnj/"
  },
  {
   "rank": 24,
   "holding": "Eton Pharmaceuticals Inc",
   "ticker": "ETON",
   "weight_pct": 1.888,
   "page": null
  },
  {
   "rank": 25,
   "holding": "Definium Therapeutics Inc",
   "ticker": "DFTX",
   "weight_pct": 1.885,
   "page": null
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "SSI US Gov Money Market Class",
   "weight_pct": 0.081
  },
  {
   "holding": "US Dollar",
   "weight_pct": 0.0
  },
  {
   "holding": "Cash and other net assets",
   "weight_pct": -0.03
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/xph/holdings/xph-holdings.csv",
 "json_book": "https://etfiq.com/data/books/xph.json",
 "markdown": "https://etfiq.com/funds/xph/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of XPH, data as of Oct 13, 2026. https://etfiq.com/funds/xph/holdings/"
}